Santhera (@Santhera) header
Santhera (@Santhera) profile picture

#Santhera is passionate about improving the lives of patients suffering from a rare disease. #Duchenne #DMD #neuromuscular #theirfutureourfocus #raredisease

Pratteln, Switzerland
Joined July 2009
Photo by Santhera (@Santhera)Photo by Santhera (@Santhera)Photo by Santhera (@Santhera)Photo by Santhera (@Santhera)Photo by Santhera (@Santhera)Photo by Santhera (@Santhera)Photo by Santhera (@Santhera)Photo by Santhera (@Santhera)Photo by Santhera (@Santhera)Photo by Santhera (@Santhera)
It’s often thought that, because DMD impacts muscle repair, people living with the condition should avoid exercise. In fact, staying active can play an important role in supporting physical function, but it’s about finding the right balance and the right kind of activity. Gentle, low-impact movement such as swimming or stretching, guided by a healthcare team, can help maintain flexibility, support joint health and promote overall wellbeing as well as providing valuable opportunities to socialise.¹⁻² By replacing misinformation with understanding, we can empower people with DMD and their families to make informed decisions and thrive, on the court, in the pool, or wherever suits them. #DMD #RareDisease #PatientSupport #ActiveDMD #Santhera #DMDmyths
1
94
Duchenne muscular dystrophy (DMD) isn’t just a childhood condition. Thanks to advances in diagnosis, multidisciplinary care and treatment, nearly 9 in 10 people with DMD now live to celebrate their 20th birthday, and many are living into their 30s.¹˒² However, too many assumptions about DMD remain rooted in the past. As people with DMD are living longer, they deserve healthcare, support systems and opportunities that reflect the realities of adulthood. It's time to move beyond old stereotypes and recognise that DMD is a lifelong condition. By raising awareness, challenging misconceptions and advocating for continued investment in research, care and equitable access to treatment, we can change the conversation around DMD—because progress in medicine should also be matched by progress in understanding. #DMD #RareDisease #DuchenneAwareness #Santhera
3
129
Many people know DMD as a genetic condition, naturally assuming a family history is required to develop it. However, approximately one in three DMD cases arise because of a random mutation, meaning it can occur without any previous family record.¹ Recognising DMD early is therefore important, even in those you might not suspect. Look out for symptoms such as difficulties in running, jumping, frequent falls, trouble climbing stairs, toe walking, Gowers' Sign (using a walking motion with hands to stand up), or enlarged calf muscles.² Acting early means access to care, support, and interventions that could make a huge difference. #DMD #RareDisease #EarlyDiagnosis #TestDMD #Santhera #DMDmyths
4
99
The way Duchenne muscular dystrophy (DMD) is talked about shapes how people living with the condition are seen, supported and included. DMD is a lifelong condition, but it does not define a person’s ambitions, achievements or identity. Choosing language that reflects independence, individuality and possibility helps challenge outdated perceptions and creates a more inclusive conversation. Small changes in the words we use can make a big difference: ❌ “Suffers from DMD” ✅ “Lives with DMD” People with DMD can thrive, and to imply that they ‘suffer’ is to take away all the joy they gain from life every day. ❌ “Confined to a wheelchair” ✅ “Uses a wheelchair for mobility” A wheelchair is a tool and a powerful one at that, it’s as non-sensical as saying someone is confined to their running shoes when out for a jog. ❌ “DMD patients are unable to…” ✅ “People living with DMD may experience…” DMD affects everyone differently, and individual experiences vary. People living with DMD are students, professionals, friends, family members and advocates. They have goals, passions and stories that extend far beyond their diagnosis. By choosing words that empower rather than limit, we can help change the way DMD is understood, because better language leads to better awareness—and better awareness drives better support.
4
103
Caring for someone with Duchenne muscular dystrophy (DMD) is a daily act of resilience. Caregivers are central to every step of care, supporting, coordinating, and adapting as needs evolve. At Santhera we’re committed to advancing understanding and care in DMD, alongside patients, caregivers, and Healthcare professionals. #DMD #RareDisease #Caregivers #DMDAwareness #Santhera #TheirFutureOurFocus
2
115
We’re incredibly proud to celebrate the impact of our Steps for Strength campaign. Together, we moved in solidarity with the boys and caregivers living with Duchenne, showing that every step can help make a difference. And we took 25.4 million! Aligned with the 2026 World Duchenne Awareness Day theme, “Access Changes Lives,” the funds raised will be donated to @worldduchenne through Steps for Access — Santhera’s initiative supporting three projects across different regions to improve access to care, sport and mobility for people living with Duchenne. A huge thank you to everyone who took part, donated, encouraged a colleague or helped keep us moving. Together, we moved forward with purpose. 💙 #DMD #RareDisease #Santhera #TheirFutureOurFocus #WDAD2026
2
98
DMD causes progressive muscle weakness. But weakness is the last thing that defines the Duchenne community. This #DuchenneAwarenessDay, we celebrate the strength of those living with DMD, their families, caregivers &care teams. Raise awareness. Show support. Make a difference. 🎈
1
3
148
Today on #RareDiseaseDay, we highlight the power of listening. With our support, #policlinicogemelli created a documentary, sharing the stories of Enrico, Hermes & Luca - 3 young men living with #Duchenne 💛 Watch it here: youtube.com/@Santhera_Pharma…
3
3
143
Sperogenix Therapeutics, #Santhera's specialized rare disease partner for China, announced: 曙方医药杜氏肌营养不良新药Vamorolone上市许可申请获受理! China's NMPA has accepted for priority review the NDA for this new medicine to treat #DMD. More at bit.ly/43AxVoo #Duchenne
4
1
3
613
At #Santhera, we recognize the vital significance of #InternationalWomensDay in celebrating the achievements and contributions of women worldwide. Together, let's continue to champion for opportunities for women in our organization and beyond. #IWD2024 #EmpowerWomen #WomenLeaders
2
1
379
At #Santhera, we are dedicated to developing medicines to meet the needs of patients living with #raredisease. Please join us in recognizing #RareDiseaseDay on February 29, 2024, when we come together to raise awareness for rare disease! #theirfutureourfocus #Duchenne #DMD
2
1
2
341
With rare disease day coming up on February 29, Dr. Kerry Nip, our Head Medical Affairs EU & ROW, shares what it means to her in her role at Santhera. #Santhera #theirfutureourfocus #Duchenne #DMD #rarediseaseday #raredisease #showyourcolours
2
1
411
We are thrilled to announce that the U.S. FDA has approved our novel corticosteroid drug for the treatment of #Duchenne muscular dystrophy (#DMD) in children and adults aged 2 years and older. Read more here bit.ly/3Qf1tBz. #Santhera #theirfutureourfocus
3
2
20
731
#Santhera and Catalyst are proud to partner in the development of an innovative therapy to address unmet needs in the #Duchenne muscular dystrophy community! Our med reps are welcoming HCPs at #WMS2023 booth #19. #theirfutureourfocus #musculardystrophy #DMD
2
4
699
We are participating in the 2023 WMS World Muscle Society conference! Our medical representatives are looking forward to meeting health care professionals at our scientific exhibit (booth #19). #Santhera #theirfutureourfocus #Duchenne #musculardystrophy #DMD #WMS2023
2
3
549
We're at the H.C. Wainwright & Co, LLC 25th Annual Global Investment Conference in NYC! Our CEO Dario Eklund will share updates and future goals of #Santhera. Join him on Sep 12, 2023, at 10:00 AM EDT, room Kennedy II, Lotte NY Palace Hotel. #HCWainright #investorconference #DMD
2
5
479
Today, #Santhera announced its half-year 2023 results and provided updates on its business and financing initiatives. Progress made will also be shared in a conference call today at 14:30 CEST / 08:30 EST. Join us! For dial-in details and PR: bit.ly/44J2GXg.
2
3
314